Guru Ownership Trend
Guru Analysis for Cogent Biosciences, Inc. (COGT)
Cogent Biosciences, Inc. (COGT), a key player in the Healthcare sector, continues to attract institutional attention.
As of Q2 2026, a total of 5 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $78.85 M.
Top institutional holders include Renaissance Technologies (RenTech) and Steven Cohen.
Institutional sentiment is currently Slightly Bearish. This is evidenced by a $4.7 M net outflow during the quarter.
Recent activity highlights Jefferies Group who increased their stake by 238.6%. Conversely, Steven Cohen reduced exposure by 47.3%.
Key Holders
Top 5 by Value
Top 5 by Conviction
Recent Activity Breakdown (Q2 2026)
Guru Consensus (Q2 2026)
FAQs for Cogent Biosciences, Inc. (COGT)
Major holders include Renaissance Technologies (RenTech) ($38.55 M), Steven Cohen ($28.8 M), Cliff Asness ($11.41 M). According to the latest reported data, 5 tracked investment managers collectively hold approximately 2.41 M shares.
According to the latest 13F reporting period, sentiment appears Bearish (Net Selling). There was a net outflow of $4.7 M, with 4 managers increasing positions and 1 managers reducing holdings.
During the most recent reporting period, 1 managers trimmed their positions, while 0 fully exited COGT. The total reported sell value was $25.8 M.
Yes, 0 managers opened new positions in COGT, and 4 increased their existing holdings. The total reported buy value was $21.09 M.